AI MARKET SCANNING

$AIM

AIM ImmunoTech Inc.

United StatesUNITED STATES
FREE PREVIEW
🌐 Website🏛️ NYSE American📁 Healthcare🏭 Biotechnology
AVG HISTORICAL GAP1.47%
MAX GAP RECORD12.00%
PREMIUM
AI ACCURACY RATE
92.4%
Unlock AI Insights 🔓

LAST 10 EARNINGS GAPS (%)

QUANTITATIVE LIVE RADAR BLOTTER

Institutional execution stream for $AIM

EXECUTIONS0
WIN RATE••.•%
NET ROI+•••.••%
Execution DateStrategy & SetupDirectionExecution RangeHold TimeExit TriggerNet PnL
RADAR SCANNING: WAITING FOR NEXT CATALYST
🔒 Institutional Data Protected

Exact execution prices, stop-loss triggers, and full trade logs are reserved for PRO members.

UNLOCK FULL BLOTTER

VOLATILITY & BIAS PROFILE

AVG VOLATILITY4.7%
Bullish Gaps
Bearish Gaps
Neutral

Intelligence Brief

AIM ImmunoTech Inc., an immuno-pharma company, engages in the research and development of therapeutics to treat multiple types of cancers, viral diseases, and immune-deficiency disorders in the United States. The company's flagship products are Ampligen (rintatolimod), a drug of large macromolecular double-stranded ribonucleic acid molecules to treat chronic fatigue syndrome; and Alferon N Injection (Interferon alfa), a purified, natural-source, glycosylated,… Read full dossier

CURRENT AI SIGNAL
BULLISH STRONG
🔓 REVEAL SIGNAL

AI INSIGHTS & REPORTS FOR $AIM

AI REPORT
Sep 13

This Week in Quant: A Deeper Dive into Market Dynamics

AnalysisMarkets this week exhibited a mix of volatility and strategic positioning as participants adapted to shifting macroeconomic signals.…
VIEW REPORT_
AI REPORT
Sep 10

Lindex Group Oyj: In-Depth Forecast and Technical Analysis for 2024

Understanding Financial Markets with Technical Indicators Financial markets are inherently unpredictable, but advanced technical analysis tools like RSI…
VIEW REPORT_
AI REPORT
Sep 09

Lindex Group Oyj Forecast and Analysis: Predicting Market Trends with Technical Indicators

Lindex Group Oyj: A Closer Look at Financial Performance In the ever-evolving financial landscape, analyzing companies like Lindex…
VIEW REPORT_